United States · Financial press · Barron's
Moderna Stock Plummets 25% After Cancer-Vaccine Data Leak
Moderna shares tumbled as reported results for its cancer vaccine with Merck circulated ahead of a planned conference presentation.
Read the full article on Barron's Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.barrons.com)
